TNIK and cancer: In the present study, we conducted comprehensive modeling studies of TNIK inhibitors and developed CoMFA/CoMSIA, kNN, and CoMSIA-SIMCA models, which were then rationally applied to screen and identify an approved drug, mebendazole, as a potent TINIK inhibitor for cancer therapy.